Skip to content

Marie Claire Van Hout

5 papers in the library · 252 citations · publishing 2013-2024

Papers

Sort Most recent Most cited

Psychiatric and legal considerations for ketamine treatment within prison settings.

Frontiers in Psychiatry 2024 Michael Bayrhammer-Savel, Martin Ortner, Marie Claire Van Hout et al. 6 citations

The fundamental right to equivalence of health care in prison settings encompasses the provision of medication to address mental health conditions. Considering the increased risk for self-harm among individuals dealing with depression, the limited effectiveness of conservative antidepressants is a major challenge in psychiatry. The high prevalence of suicidal tendencies within prison...

Why do people use new psychoactive substances? Development of a new measurement tool in six European countries.

Journal of psychopharmacology (Oxford, England) June 1, 2020 Annemieke Benschop, Róbert Urbán, Máté Kapitány-fövény et al. 35 citations

New psychoactive substances (NPS) pose a public health threat. Many studies have tried to identify the reasons of NPS use; however, none of them have so far used any standardised measures. The aim of this study was (i) to develop and cross-culturally validate the New Psychoactive Substance Use Motives Measure (NPSMM) and (ii) to compare motives of NPS use across countries and user types. Three...

"Trip-Sitting" in the Black Hole: A Netnographic Study of Dissociation and Indigenous Harm Reduction.

Journal of Psychoactive Drugs 2016 Evelyn Hearne, Marie Claire Van Hout

An array of dissociative novel psychoactive substances, including "methoxetamine," "3-MeO-PCP," and "methoxphenidine," have emerged as substitutes for the illicit substance "ketamine." A netographic research methodology aimed to describe online, dissociative novel psychoactive substance users' perceptions of risk, informed knowledge around use, and indigenous harm-reduction practices as...

"Word of mouse": indigenous harm reduction and online consumerism of the synthetic compound methoxphenidine.

Journal of Psychoactive Drugs 2015 Marie Claire Van Hout, Evelyn Hearne

Methoxphenidine (MXP) was one of several NMDA antagonists marketed in 2013 to replace the recently controlled compound Methoxetamine (MXE). A steep rise in user interest was recorded, despite vendor cautioning of limited user feedback. The study presented a phenomenological analysis of MXP experiences amongst recreational drug users as posted on public Internet fora. Internet searches were...

'Surfing the Silk Road': a study of users' experiences.

The International journal on drug policy November 1, 2013 Marie Claire Van Hout, Tim Bingham 211 citations

The online drug marketplace called 'Silk Road' has operated anonymously on the 'Deep Web' since 2011. It is accessible through computer encrypting software (Tor) and is supported by online transactions using peer to peer anonymous and untraceable crypto-currency (Bit Coins). The study aimed to describe user motives and realities of accessing, navigating and purchasing on the 'Silk Road'...